Anti-obesity medication/ja: Difference between revisions

Anti-obesity medication/ja
Created page with "===撤退==="
Created page with "{| class="wikitable" |+ !医薬品名 !商品名 !作用機序 !現在のFDAステータス !プラセボ調整による体重減少率(最高用量試験) |- |Lorcaserin/ja |ベルヴィーク |5-HT2C receptor/ja作動薬 |安全上の理由により中止 | 6.25 % |- |Sibutramine/ja |メリディア |Serotonin–norepinephrine reuptake inhibitor/ja |心血管系リスクにより中止 | 19.7 % |- |Rimonabant/ja |アコンプリア、ジンブ..."
Tags: Mobile edit Mobile web edit
Line 118: Line 118:
===撤退===
===撤退===


<div lang="en" dir="ltr" class="mw-content-ltr">
{| class="wikitable"
{| class="wikitable"
|+
|+
!Medication Name
!医薬品名
!Trade name(s)
!商品名
!Mechanism of action
!作用機序
!Current FDA Status
!現在のFDAステータス
!placebo-adjusted percent bodyweight lost (highest dose studied)
!プラセボ調整による体重減少率(最高用量試験)
|-
|-
|[[Lorcaserin]]
|[[Lorcaserin/ja]]
|Belviq
|ベルヴィーク
|[[5-HT2C receptor]] agonist
|[[5-HT2C receptor/ja]]作動薬
|Withdrawn for safety reasons
|安全上の理由により中止
| 6.25 percent
| 6.25 %
|-
|-
|[[Sibutramine]]
|[[Sibutramine/ja]]
|Meridia
|メリディア
|[[Serotonin–norepinephrine reuptake inhibitor]]
|[[Serotonin–norepinephrine reuptake inhibitor/ja]]
|Withdrawn due to cardiovascular risks
|心血管系リスクにより中止
| 19.7 percent
| 19.7 %
|-
|-
|[[Rimonabant]]
|[[Rimonabant/ja]]
|Acomplia, Zimbutli
|アコンプリア、ジンブトリ
|[[Cannabinoid receptor antagonist]]
|[[Cannabinoid receptor antagonist/ja]]
|Withdrawn for safety reasons
|安全上の理由により中止
| {{convert|2.6 to 6.3|kg}}
| {{convert|2.6 to 6.3|kg}}
|-
|-
|[[Fenfluramine]]
|[[Fenfluramine/ja]]
|
|
|[[Serotonin releasing agent]]
|[[Serotonin releasing agent/ja]]
|Withdrawn for safety reasons
|安全上の理由により中止
| -
| -
|-
|-
|[[Fenfluramine/phentermine]] (fen-phen)
|[[Fenfluramine/phentermine/ja]] (フェンフェン)
|Pondimin
|ポンディミン
|
|
|Withdrawn for safety reasons
|安全上の理由により中止
|13.9 percent
|13.9 %
|-
|-
|[[Dexfenfluramine]]
|[[Dexfenfluramine/ja]]
|Redux
|リダックス
|[[Serotonin releasing agent]]
|[[Serotonin releasing agent/ja]]
|Withdrawn for safety reasons
|安全上の理由により中止
|{{convert|3.5|kg}}
|{{convert|3.5|kg}}
|-
|-
|[[2,4-Dinitrophenol]]
|[[2,4-Dinitrophenol/ja]]
|
|
|[[Uncoupling agent]]
|[[Uncoupling agent/ja]]
|Withdrawn for safety reasons
|安全上の理由により中止
|{{convert|17.1|lb}} per patient on average (uncontrolled study)
|{{convert|17.1|lb}} 患者1人当たり平均(非対照試験)
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">